The results demonstrated that treatment of lung cancer A549 cells with LPS and ATP induced the expression of IL-6 and inflammasome-related cytokines IL-1β and IL-18, as well as increased NLRP3 gene expression. The gene discussed is IL1B; the disease is lung cancer.